CD8+ T cells activated during the course of murine acute myelogenous leukemia elicit therapeutic responses to late B7 vaccines after cytoreductive treatment

Blood

Volumn 89, Issue 8, 1997, Pages 2915-2924

  Dunussi Joannopoulos, Kyriaki ^a,b   Krenger, Werner ^a   Weinstein, Howard J ^a   Ferrara, James L M ^a   Croop, James M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD8 ANTIGEN; CYTARABINE; GAMMA INTERFERON; INTERLEUKIN 2; VACCINE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR GROWTH; VACCINATION;

EID: 0030945008     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2915     Document Type: Article

References (55)

1. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643, 1991
2. Urban JL, Schreiber H: Tumor-antigens. Annu Rev Immunol 10:617, 1992
3. Boon T, Cerottini J-C, Van den Eynde B, Van der Bruggen P, Van Pel A: Tumor-antigens recognized by T lymphocytes. Annu Rev Immunol 12:337, 1994
4. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA: Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. PNAS 91:3515, 1994
5. Kawakami Y, Eliyahu S, Jennings C, Sakaguchi K, Kang X, Southwood S, Robbins PF, Sette A, Appella E, Rosenberg SA: Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 154:3961, 1995
6. Robbins PF, el-Gamil M, Li YF, Topalian SL, Rivoltini L, Sakaguchi K, Appella E, Kawakami Y, Rosenberg SA: Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J Immunol 154:5944, 1995
7. Van Pel A, Van der Bruggen P, Coulie PG, Brichard VG, Lethe B, Van den Eynde B, Uyttenhove C, Renauld J-C, Boon T: Genes coding for tumor-antigens recognized by cytolytic lymphocytes. Immunol Rev 145:229, 1995
8. Henderson RA, Finn OJ: Human tumor antigens are ready to fly. Adv Immunol 62:217, 1996
9. Schwartz RH: Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065, 1992
10. Gajewski TF, Fallarino F, Uyttenhove C, Boon T: Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor. J Immunol 156:2909, 1996
11. Colombo MP, Forni G: Cytokine gene transfer in tumor inhibition and tumor therapy: Where are we now? Immunol Today 15:48, 1994
12. Dranoff G, Mulligan RC: Gene transfer as cancer therapy. Adv Immunol 58:417, 1995
13. Pardoll DM: Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol 13:399, 1995
14. Liu Y, Linsley PS: Costimulation of T-cell growth. Curr Opin Immunol 4:265, 1992
15. Chen L, Linsley PS, Hellström KE: Costimulation of T cells for tumor immunity. Immunol Today 14:483, 1993
16. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191, 1993
17. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 15:321, 1994
18. Chen L, Ashe S, Brady WA, Hellström I, Hellström KE, Ledbetter JA, McGowan P, Linsley P: Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093, 1992
19. + T cells by B7-transfected melanoma cells. Science 259:368, 1993
20. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LN, Freeman GJ, Glimcher LH: Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 90:5687, 1993
21. Hodge JW, Abrams S, Schlom J, Kantor JA: Induction of antitumor immunity by recombinant vaccinia viruses expressing B7.1 or B7.2 costimulatory molecules. Cancer Res 54:5552, 1994
22. Matulonis UA, Dosiou C, Lamont C, Freeman GJ, Mauch P, Nadler LM, Griffin JD: Role of B7.1 mediating an immune response to myeloid leukemia cells. Blood 85:2507, 1995
23. Dunussi-Joannopoulos K, Weinstein HJ, Nickerson PW, Strom TB, Burakoff SJ, Croop JM, Arceci RJ: Irradiated B7.1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood 87:2938, 1996
24. Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Tamai M, Noguchi K, Hotta T: Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients. Int J Cancer 51:67, 1992
25. Ochoa AC, Longo DL: Alteration of signal transduction in T cells from cancer patients, in De Vita VT, Hellman S, Rosenberg SA (eds): Important Advances in Oncology. Philadelphia, PA, Lippincott, 1995, p 43
26. Schoof DD, Terashima Y, Peoples GE, Goedegebuure PS, Andrews JV, Richie JP, Eberlein TJ: CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. Cell Immunol 150:114, 1993
27. Ghosh P, Komschlies KL, Cippitelli M, Longo DL, Subleski J, Ye J, Sica A, Young HA, Wiltrout RH, Ochoa AC: Gradual loss of T-helper 1 population in spleen of mice during progressive tumor growth. J Natl Cancer Inst 87:1478, 1995
28. Zen HJ, Hurd S, Storkus WJ, Lotze MT: Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: Implications for the immunotherapy in cancer. J Immunother 14:155, 1993
29. Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S, Billet A, Sallan SE, Gribben JG, Nadler LM: Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 88:41, 1996
30. Resnitzky P, Estrov Z, Haran-Ghera N: High incidence of acute myeloid leukemia in SJL/J mice after x-irradiation and corticosteroids. Leuk Res 9:1519, 1985
31. Marshak-Rothstein A, Fink P, Gridley T, Raulet DH, Bevan MJ, Gefter ML: Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J Immunol 122:2491, 1979
32. Spitalny G, Havell E: Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 159:1560, 1984
33. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR: Two types of mouse helper T cell clones: III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 166:1229, 1987
34. Ohara J, Paul WE: Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:33, 1985
35. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE: Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127:5, 1992
36. Mosmann TR, Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145, 1989
37. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138, 1996
38. Wierenga EA, Snoek M, de Groot C, Chretien I, Bos JD, Jansen HM, Kapsenberg ML: Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol 144:4651, 1990
39. + T cells. Ann Rev Immunol 12:635, 1994
40. Mossmann TR, Moore KW: The role of IL-10 crossregulation of Th1 and Th2 responses. Immunol Today 12: A49, 1994
41. Ben-Ishay Z, Prindull G, Sharon S: Improved prognosis in mice with advanced myeloid leukemia following administration of GM-CSF and cytosine arabinoside. Leuk Res 15:321, 1991
42. Mueller DL, Jenkins MK, Schwarz RH: Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Ann Rev Immunol 7:445, 1989
43. Schwarz RH: A cell culture model for T lymphocyte clonal anergy. Science 248:1349, 1990
44. + T cells. Science 271:1272, 1996
45. Migifa K, Eguchi K, Kawabe Y, Tsukada T, Ichinose Y, Nagataki S: Defective TcR-mediated signaling in anergic T cells. J Immunol 155:5083, 1995
46. Kersh GJ, Allen PM: Essential flexibility in the T-cell recognition of antigen. Nature 380:495, 1996
47. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffe E, Pardoll M, Levitsky H: Role of bone-marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961, 1994
48. Huang AYC, Bruce AT, Pardoll DM, Levitsky HI: Does B7.1 expression confer antigen-presenting cell capacity to tumors in vivo? J Exp Med 183:769, 1996
49. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT: Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1:1297, 1995
50. Viola A, Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104, 1996
51. Lanzaveccia A: T cell clones retained small numbers of TcRs for as long as 5 to 8 days after stimulation, in Matzinger P, Flaginek M, Rammensee H-G, Storkinger G, Rolink T, Nicklin L (eds): The Tolerance Workshop 1986. Basel, Switzerland, Roche, 1986, p 293
52. Chen L, McGowan P, Ashe S, Johnston JV, Hellström I, Hellström KE: B7.1/CD80 transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Cancer Res 54:5420, 1994
53. Chen L, McGowan P, Ashe S, Johnston JV, Li Y, Hellström I, Hellström KE: Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med 179:523, 1994
54. Ahmed R, Gray D: Immunological memory and protective immunity: Understanding their relation. Science 272:54, 1996
55. Swain SL, Croft M, Dubey C, Haynes L, Rogers P, Zhang X, Bradley LM: From naive to memory cells. Immunol Rev 150:143, 1996